Atherosclerosis
Cardiovascular·MeSH: Atherosclerosis
5 drugs in development·3 companies·6 clinical trials
Drug Pipeline by Phase
Approved(1)
| Drug | Company |
|---|---|
| pravastatin | Aptinyx Inc. (APTX) |
Phase 3(2)
Phase 1(1)
| Drug | Company |
|---|---|
| aem-28 | Capstone Holding Corp. (CAPS) |
Preclinical(1)
| Drug | Company |
|---|---|
| aem-28-08 | Capstone Holding Corp. (CAPS) |
Compare drugs
Frequently asked questions
How many drugs are in development for Atherosclerosis?
BioSniper tracks 5 drugs in development for Atherosclerosis across 3 companies.
How many clinical trials target Atherosclerosis?
There are 6 clinical trials targeting Atherosclerosis tracked by BioSniper.
Deep-dive into Atherosclerosis
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis